Rock Springs Capital Management LP 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:49 pm Purchase |
2024-09-30 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 47,670,850 6.200% |
7,751,595 (+19.42%) |
Filing |
| 2024-02-14 2:11 pm Unchanged |
2023-12-31 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 39,919,255 5.690% |
0 (Unchanged) |
Filing |
| 2024-02-14 2:10 pm Purchase |
2023-07-03 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 39,919,255 6.380% |
8,694,770 (+27.85%) |
Filing |
| 2023-02-14 2:55 pm Purchase |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 31,224,485 5.340% |
25,638,864 (+459.02%) |
Filing |
| 2022-02-15 12:44 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 5,585,621 5.130% |
5,585,621 (New Position) |
Filing |